Lentivector licensing agreement with Biogen Idec Inc
Lentivector licensing agreement with Biogen Idec Inc
Oxford BioMedica has entered into an agreement to license its LentiVector technology to Biogen Idec for use in research activities
Note: Readers of the Editor’s free email newsletter will have read this news when it was announced. Send us a blank email now to join the circulation. It’s free!
Oxford BioMedica will receive an upfront licence payment and an annual maintenance fee. Further financial details were not disclosed. LentiVector, a lentivirus-based system, is one of the most powerful technologies available for gene delivery to a wide range of cell and tissue types.
The technology has applications both in therapeutic products and drug discovery, as a tool for target validation and the creation of targeted disease models.
Oxford BioMedica has entered into an agreement to license its LentiVector technology to Biogen Idec for use in research activities
Note: Readers of the Editor’s free email newsletter will have read this news when it was announced. Send us a blank email now to join the circulation. It’s free!
Oxford BioMedica will receive an upfront licence payment and an annual maintenance fee. Further financial details were not disclosed. LentiVector, a lentivirus-based system, is one of the most powerful technologies available for gene delivery to a wide range of cell and tissue types.
The technology has applications both in therapeutic products and drug discovery, as a tool for target validation and the creation of targeted disease models.
posted by Famous Quotations - Lentivector licensing agreement with Biogen Idec Inc
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home